Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

January 16, 2022

Durable Metabolic Improvements 2 Years After Duodenal Mucosal Resurfacing (DMR) in Patients With Type 2 Diabetes (REVITA-1 Study).

Diabetes Research and Clinical Practice
Annieke C G van BaarJacques Jghm Bergman
January 16, 2022

An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine.

Nitric Oxide : Biology and Chemistry
Angelo Zinellu, Arduino A Mangoni
January 16, 2022

Determinants of longevity and age at death in a practically extinct cohort of middle-aged men followed-up for 61 years.

Aging Clinical and Experimental Research
Alessandro MenottiGiovina Catasta
January 16, 2022

Secondary Stroke Risk Reduction in Black Adults: a Systematic Review.

Journal of Racial and Ethnic Health Disparities
Caroline CaoCarolyn Harmon Still
January 16, 2022

Dietary interventions and blood pressure in overweight or obese individuals: A systematic review and meta-analysis.

Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Karla ArnottiVeronica Brewer
January 16, 2022

Temporal Trends in Use of Complementary Therapies Among Patients With Cardiovascular Disorders.

The American Journal of Cardiology
Kavita PrasadDietlind L Wahner-Roedler
January 16, 2022

Leg and arm adiposity is inversely associated with diastolic hypertension in young and middle-aged United States adults.

Clinical Hypertension
Aayush VisariaParag Joshi
January 15, 2022

Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults.

Journal of the American College of Cardiology
Marta Guasch-FerréFrank B Hu
January 15, 2022

Prevalence and prognosis of refractory hypertension diagnosed using ambulatory blood pressure measurements.

Hypertension Research : Official Journal of the Japanese Society of Hypertension
Minjae YoonSungha Park
January 15, 2022

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).

Nature Medicine
Michael J KorenGerald F Watts
January 15, 2022

Plant-based dietary quality and depressive symptoms in Australian vegans and vegetarians: a cross-sectional study.

BMJ Nutrition, Prevention & Health
Megan Frances LeeTalitha Best
January 15, 2022

Comparing McDonald's food marketing practices on official Instagram accounts across 15 countries.

BMJ Nutrition, Prevention & Health
Omni CassidyMarie Bragg
January 15, 2022

Fatty Acid Composition of Grain- and Grass-Fed Beef and Their Nutritional Value and Health Implication.

Food Science of Animal Resources
Kim Margarette C NogoySungkwon Park
January 15, 2022

Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative.

Nicholas B HuntRudolf A de Boer

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2022 Meta ULC. All rights reserved